ClinConnect ClinConnect Logo
Search / Trial NCT06242717

Postpartum Screening for Anxiety and Comorbid Conditions

Launched by UNIVERSITY OF BRITISH COLUMBIA · Feb 1, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and improving how we screen for postpartum anxiety and related conditions in new mothers in British Columbia, Canada. The study aims to gather information from about 550 women who are 4 to 8 weeks postpartum by having them fill out a series of seven questionnaires. These questionnaires will help identify levels of anxiety, depression, social support, pain, quality of life, anger, and sleep issues.

To participate, women need to be at least 19 years old, have given birth in British Columbia within the last 4 to 8 weeks, and be comfortable communicating in English. There are no specific health conditions that would exclude someone from joining. Participants can expect to complete the questionnaires online and may also be invited to a follow-up interview to share their experiences with the screening process. This study hopes to find effective ways to support new mothers' mental health and overall well-being during the postpartum period.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • ≥ 19 years
  • 4-8 weeks postpartum
  • Proficiency to participate in English
  • Delivered within the province of British Columbia, Canada
  • Exclusion Criteria:
  • None.

About University Of British Columbia

The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.

Locations

Vancouver, British Columbia, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported